Oncogenic mutational networks in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)
What are the genetic and environmental risk factors for chronic lymphoblastic leukemia (CLL)?
Are prognostic factors the key to precision medicine in CLL?
Precision medicine for MDS, what drugs for which patients?
Using computational algorithms to predict the response of MDS patients to hypomethylating agents